DK3532470T3 - Oxazolderivater til anvendelse som irak-hæmmere og fremgangsmåde til fremstilling deraf - Google Patents

Oxazolderivater til anvendelse som irak-hæmmere og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK3532470T3
DK3532470T3 DK17797495.3T DK17797495T DK3532470T3 DK 3532470 T3 DK3532470 T3 DK 3532470T3 DK 17797495 T DK17797495 T DK 17797495T DK 3532470 T3 DK3532470 T3 DK 3532470T3
Authority
DK
Denmark
Prior art keywords
iraq
inhibitors
preparation
oxazole derivatives
oxazole
Prior art date
Application number
DK17797495.3T
Other languages
Danish (da)
English (en)
Inventor
Hui Li
Thilo Heckrodt
Yan Chen
Ryan Kelley
Darren Mcmurtrie
Kin Tso
Vanessa Taylor
Rajinder Singh
Rose Yen
Jack Maung
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of DK3532470T3 publication Critical patent/DK3532470T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK17797495.3T 2016-10-26 2017-10-25 Oxazolderivater til anvendelse som irak-hæmmere og fremgangsmåde til fremstilling deraf DK3532470T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662413217P 2016-10-26 2016-10-26
PCT/US2017/058339 WO2018089199A1 (en) 2016-10-26 2017-10-25 Oxazole derivatives for use as irak inhibitors and method for their preparation

Publications (1)

Publication Number Publication Date
DK3532470T3 true DK3532470T3 (da) 2023-02-20

Family

ID=60302473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17797495.3T DK3532470T3 (da) 2016-10-26 2017-10-25 Oxazolderivater til anvendelse som irak-hæmmere og fremgangsmåde til fremstilling deraf

Country Status (9)

Country Link
US (4) US10370367B2 (https=)
EP (1) EP3532470B1 (https=)
JP (2) JP7170634B2 (https=)
CN (1) CN110099899B (https=)
CA (1) CA3041587A1 (https=)
DK (1) DK3532470T3 (https=)
ES (1) ES2939232T3 (https=)
PT (1) PT3532470T (https=)
WO (1) WO2018089199A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110862375B (zh) * 2018-08-27 2022-10-25 深圳铂立健医药有限公司 吡唑化合物及其药物组合物和应用
MX2022001596A (es) * 2019-08-08 2022-03-11 Rigel Pharmaceuticals Inc Compuestos y metodos para tratar sindrome de liberacion de citocinas.
PE20220970A1 (es) * 2019-08-30 2022-06-10 Rigel Pharmaceuticals Inc Compuestos de pirazol, formulaciones de los mismos y un metodo para usar los compuestos y/o formulaciones
IL315677A (en) 2022-03-23 2024-11-01 Rigel Pharmaceuticals Inc Pyrimid-2-yl-pyrazole compounds as irak inhibitors
CN121270516A (zh) * 2024-07-03 2026-01-06 科辉智药(深圳)新药研究中心有限公司 一种irak抑制剂化合物的晶型及其制备方法和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4738851A (en) 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
DK0431519T3 (da) 1989-12-04 1994-07-04 Searle & Co System til transdermal indgivelse af albuterol
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
DE69228827T2 (de) 1991-12-18 1999-10-21 Minnesota Mining And Mfg. Co., Saint Paul Mehrschichtige sperrstrukturen
ATE132381T1 (de) 1992-01-29 1996-01-15 Voelkl Franz Ski Ballspielschläger, insbesondere tennisschläger
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6197934B1 (en) 1998-05-22 2001-03-06 Collagenesis, Inc. Compound delivery using rapidly dissolving collagen film
WO2006070198A1 (en) * 2004-12-30 2006-07-06 Astex Therapeutics Limited Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
JP2012254939A (ja) * 2009-10-07 2012-12-27 Astellas Pharma Inc オキサゾール化合物
JP6787892B2 (ja) 2014-11-20 2020-11-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Irakインヒビターとしてのヘテロアリール化合物及びその使用
LT3286181T (lt) * 2015-04-22 2021-04-26 Rigel Pharmaceuticals, Inc. Pirazolo junginiai ir junginių gamybos bei naudojimo būdas
JP2019196309A (ja) 2016-09-15 2019-11-14 武田薬品工業株式会社 複素環化合物

Also Published As

Publication number Publication date
US20210179601A1 (en) 2021-06-17
JP7170634B2 (ja) 2022-11-14
ES2939232T3 (es) 2023-04-20
US10370367B2 (en) 2019-08-06
CA3041587A1 (en) 2018-05-17
CN110099899B (zh) 2024-01-02
WO2018089199A1 (en) 2018-05-17
US11492349B2 (en) 2022-11-08
JP2023011795A (ja) 2023-01-24
US20190300518A1 (en) 2019-10-03
JP2019537577A (ja) 2019-12-26
US20230062818A1 (en) 2023-03-02
US20180111923A1 (en) 2018-04-26
JP7379640B2 (ja) 2023-11-14
EP3532470A1 (en) 2019-09-04
US10941140B2 (en) 2021-03-09
CN110099899A (zh) 2019-08-06
EP3532470B1 (en) 2022-12-07
US11993594B2 (en) 2024-05-28
PT3532470T (pt) 2023-02-28

Similar Documents

Publication Publication Date Title
DK3536685T3 (da) Bicyklisk-fusionerede heteroaryl- eller arylforbindelser og anvendelse deraf som irak4 inhibitorer
DK3984996T3 (da) Aminopyridin-SSAO-inhibitorer
DK3119762T3 (da) Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft
DK3277681T3 (da) Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer
DK3233863T3 (da) Kondenserede ringheteroarylforbindelser og anvendelse deraf som trk-hæmmere
DK3221306T3 (da) Heteroarylforbindelser som irak-inhibitorer og anvendelser deraf
DK3149001T3 (da) Hidtil ukendte pyrazolopyrimidinderivater og deres anvendelse som MALT1-hæmmere
DK3464271T3 (da) Pyrazolderivater som plasma-kallikreininhibitorer
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3294738T3 (da) Mono- og disubstituerede indolderivater som inhibitorer af replikation af denguevirus
DK3200615T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
LT3137169T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3092256T3 (da) Forbindelser og sammensætninger til immunterapi
LT3160956T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
DK3177608T3 (da) Proteinkinase-C-hæmmere og fremgangsmåder til anvendelse deraf
LT3164380T (lt) Lizinui specifiniai demetilazės-1 inhibitoriai
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3286177T3 (da) Quinolinderivater som tam rtk-inhibitorer
IL254779A0 (en) Methods of administering glutaminase inhibitors
BR112017000042A2 (pt) inibidores de desmetilase-1 lisina-específica
DK3416956T3 (da) Methylaminderivater som lysyloxidasehæmmere til cancerbehandling
DK3313833T3 (da) Forbindelser og anvendelse deraf som inhibitorer af n-myristoyl-transferase
DK3341379T3 (da) EZH2-hæmmere
DK3494120T3 (da) Oxadiazolopyridinderivater til anvendelse som ghrelin-o-acyl-transferase-(goat)-inhibitorer